Table 3

Baseline characteristics of patients with STEMI aged ≥75 years in Alberta, 2006–2011

No reperfusion (n=193)Primary PCI (n=293)Fibrinolysis (n=160)p Value
Age (year), median (IQR)83 (79–87)80 (78–84)81 (78–86)<0.001
Female98 (50.8)140 (47.8)65 (40.6)0.151
BMI (kg/m2), median (IQR)26.6 (23.2–30.5)25.9 (23.0–28.8)26.6 (24.0–30.7)0.028
SBP (mm Hg), mean (SD)136 (35)139 (34)134 (30)0.371
Killip class >133 (35.5)28 (18.7)12 (15.8)0.002
Prior angina66 (34.2)79 (27.0)37 (23.1)0.058
Previous MI55 (28.5)60 (20.5)32 (20.0)0.075
Prior coronary revascularisation23 (11.9)39 (13.3)18 (11.2)0.794
Hypercholesterolaemia73 (37.8)126 (43.0)65 (40.6)0.523
Hypertension128 (66.3)200 (68.3)109 (68.1)0.895
Diabetes52 (26.9)58 (19.8)16 (10.0)<0.001
Early CAD19 (9.8)28 (9.6)14 (8.8)0.937
Chronic treatment with Aspirin60 (31.1)73 (24.9)45 (28.1)0.324
Previous heart failure4 (2.1)5 (1.7)6 (3.8)0.394
Atrial fibrillation4 (2.1)6 (2.0)4 (2.5)0.941
Symptom onset to FMC (min), median (IQR)115 (47–458)92 (39–266)85 (39–184)0.127
  • Data are presented as n (%).

  • BMI, body mass index; CAD, coronary artery disease; FMC, first medical contact; MI, myocardial infarction; PCI, percutaneous coronary intervention; SBP, systolic blood pressure.